Wockhardt Ltd
Dr. Satish Birajdar is a Senior Research Scientist at Wockhardt Research Centre in Aurangabad, where work in the New Drug Discovery Department has been ongoing since February 2008. Prior to this role, Dr. Birajdar served as an executive at Emcure Pharmaceuticals Limited from 2004 to 2008, focusing on the process development of active pharmaceutical ingredients and facilitating process transfers to kilo lab and pilot plant operations. Dr. Birajdar earned a Doctor of Philosophy (Ph.D.) in Organic Chemistry from Swami Ramanand Teerth Marathwada University in Nanded, completing the degree between 1995 and 2000.
This person is not in any offices
Wockhardt Ltd
1 followers
Wockhardt Limited is a pharmaceutical and biotechnology company. The Company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. Its products include Ace Proxyvon, Bio-Corneum, Aceroc, Alphadopa, Biovac Typhoid, Acetic Acid Otic Solution, Amlodipine Besylate Tablets, Adenosine Injection, Amoxicillin and Clavulanate Potassium for Oral Suspension, Azithromycin Tablets, Aciclovir Powder for Injection, Alendronic Acid, Amitriptyline, Clarithromycin, Entacapone Tablet and Flucloxacillin Injection. It operates a chain of approximately 10 super specialty hospitals, which offer treatment and care facilities in cardiology, neurosurgery, orthopedics, critical care, oncology, nephrology, urology and others. It has over 10 manufacturing plants located in India, the United Kingdom, Ireland and the United States. The Company has approximately three research centers globally.